Latest Market Risks News

Challenger Limited has reported a robust first half for the 2025 financial year, with net profit after tax climbing 28.2% and an 11.5% increase in its interim dividend, signaling strong momentum in its financial services operations.

ACDC Metals has completed a comprehensive metallurgical testwork program at its Goschen Central Project, confirming the viability of its processing flowsheet and advancing the project towards feasibility and potential offtake agreements.

Pengana International Equities Limited reported a striking 189% increase in net profit for the half-year ended December 31, 2024, alongside an 11% portfolio return and consistent fully franked dividends.

FBR Limited’s exclusive joint venture option with CRH Ventures for its Wall as a Service® offering in the US has expired without exercise, freeing the company to pursue independent financing and partnerships across key American markets.

Fiducian Group Limited reported a robust half-year result for December 2024, with revenue up 14% and net profit after tax rising 26%, underpinning a higher fully franked interim dividend.

GWR Group is actively pursuing a transformative transaction in Western Australia while maintaining a robust cash and investment position of $53.6 million. The company underscores its confidence in tungsten amid tightening global supply.

The a2 Milk Company posted robust first-half FY25 results, lifting revenue by 10.1% and net profit by 7.6%, while introducing a dividend policy for the first time. Strong English label IMF sales and liquid milk growth underpin an upgraded full-year outlook.

The a2 Milk Company has reported robust first-half FY25 results, boosting full-year guidance and declaring its inaugural dividend, underscoring confidence in its growth trajectory.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

Abacus Storage King reported a striking turnaround with a $67.8 million net profit for H1 2024, up from just $0.4 million a year earlier, alongside a raised interim distribution reflecting robust growth in the self-storage sector.

AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.

Hancock & Gore Limited (ASX: HNG) showcased a transformative year at its 121st AGM, spotlighting a strategic merger with Schoolblazer that creates a leading global uniforms platform and signals a new phase of growth and portfolio simplification.